Igc Pharma (IGC) traded flat 0 % during a 24 hours period ending at 04:34 PM Central Europe on Monday 26th. One Igc Pharma stock can currently be bought for about USD 0.25 on popular exchanges. Current supply of Igc Pharma stocks is 103.4 mn. Igc Pharma has a current market capitalization of USD 25.4 mn and approximately USD 31.1 k worth of Igc Pharma was traded on exchanges in the last 24 hours. Since last month end, Igc Pharma has traded -10.71 % down. Simple moving average of last 200 days is at USD 0.28. The highest price of past 52 weeks was recorded at USD 0.45 on 11/03/2025. 52 weeks low was at USD 0.24 on 10/23/2026.
Here is how related stocks have performed in the past 24 hours:
Metagenomi Therapeutics (MGX) traded down -1.23 % and now trades at USD 0.79. Current market capitalisation for Metagenomi Therapeutics is USD 30.4 mn.
Creative Realities (CREX) traded down -2.24 % and now trades at USD 2.18. Creative Realities has a market capitalisation of USD 29.5 mn.
Aligos Therapeutics (ALGS) traded down -0.83 % and now trades at USD 4.64. Current market capitalisation for Aligos Therapeutics is USD 29.9 mn.
Transcode Therapeutics (RNAZ) traded up 3.21 % and now trades at USD 1.74. Transcode Therapeutics has a market capitalisation of USD 30 mn.
Aardvark Therapeutics (AARD) traded down -64.81 % and now trades at USD 1.05. Current market capitalisation for Aardvark Therapeutics is USD 30.4 mn.
About Igc Pharma
IGC Pharma, Inc. is a biopharmaceutical company that specializes in developing cannabinoid-based formulations for treating various diseases and conditions. These include Alzheimer’s disease, menstrual cramps, premenstrual syndrome (PMS), and chronic pain. IGC Pharma serves the healthcare sector in the United States.
